The effect of alliances on innovation patterns: an analysis of the biotechnology industry

The purpose of this article is to show the effect of different types of alliances on the innovation patterns of successful firms in the biotechnology industry. Using a new approach to measuring changes in innovation patterns across technology classes, the results show that alliances are formed to specialize in a certain research field, rather than to enter a completely new market. The importance of this effect declines as the equity involvement of the partners in the alliance project increases. Copyright 2013 The Author 2012. Published by Oxford University Press on behalf of Associazione ICC. All rights reserved., Oxford University Press.

[1]  M. Berk Talay,et al.  Exploring Correlates of Product Launch in Collaborative Ventures: An Empirical Investigation of Pharmaceutical Alliances , 2009 .

[2]  Holger Ernst,et al.  Patent portfolios for strategic R & D planning , 1998 .

[3]  Bronwyn H Hall,et al.  The Impact of Corporate Restructuring on Industrial Research and Development , 1989, Brookings Papers on Economic Activity. Microeconomics.

[4]  R. Narula,et al.  Innovating through strategic alliances: moving towards international partnerships and contractual agreements , 1999 .

[5]  Kulwant Singh,et al.  The Impact of Technological Complexity and Interfirm Cooperation on Business Survival , 1997 .

[6]  A. P. Man,et al.  Transitory Alliances: An Instrument for Surviving Turbulent Industries? , 2003 .

[7]  Joseph E. Coombs,et al.  Measuring Technological Capability and Performance , 2006 .

[8]  Laura B. Cardinal,et al.  A Longitudinal Study of the Impact of R&D, Patents, and Product Innovation on Firm Performance , 2010 .

[9]  Olof Ejermo.  Technological diversity and Jacobs' externality hypothesis revisited , 2005 .

[10]  Rachelle C. Sampson.  R&D Alliances & Firm Performance: The Impact of Technological Diversity and Alliance Organization on Innovation , 2003 .

[11]  Noel P. Greis,et al.  Absorptive capacity and new product development , 2001 .

[12]  A. Arundel,et al.  What percentage of innovations are patented? empirical estimates for European firms , 1998 .

[13]  Henk F. Moed,et al.  An exploration of the science base of recent technology , 1990 .

[14]  Bjørn L. Basberg,et al.  Patent statistics and the measurement of technological change — an assessment of the Norwegian patent data, 1840–1980 , 1984 .

[15]  C. A. Benavides-Velasco,et al.  Innovative competence, exploration and exploitation: The influence of technological diversification , 2008 .

[16]  Gary P. Pisano,et al.  R&D Performance, Collaborative Arrangements and the Market for Know-How: A Test of the "Lemons" Hypothesis in Biotechnology , 1997 .

[17]  J. DiMasi,et al.  Risks in new drug development: Approval success rates for investigational drugs , 2001, Clinical pharmacology and therapeutics.

[18]  Charles W. L. Hill,et al.  Technological Discontinuities and Complementary Assets: A Longitudinal Study of Industry and Firm Performance , 2005, Organ. Sci..

[19]  B. Silverman.  Technological Resources and the Direction of Corporate Diversification: Toward an Integration of the Resource-Based View and Transaction Cost Economics , 1998 .

[20]  Pier Paolo Saviotti,et al.  Firm knowledge and market value in biotechnology , 2006 .

[21]  R. Gulati,et al.  The Architecture of Cooperation: Managing Coordination Costs and Appropriation Concerns in Strategic Alliances , 1998 .

[22]  J. Hagedoorn.  Understanding the rationale of strategic technology partnering: Nterorganizational modes of cooperation and sectoral differences , 1993 .

[23]  Bing-Sheng Teng,et al.  RISK TYPES AND INTER‐FIRM ALLIANCE STRUCTURES* , 1996 .

[24]  R. Calantone,et al.  Escalation of commitment during new product development , 2002 .

[25]  D. Teece.  Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy , 1993 .

[26]  G. Hamel.  Competition for competence and interpartner learning within international strategic alliances , 1991 .

[27]  Wim Vanhaverbeke,et al.  External technology sourcing: The effect of uncertainty on governance mode choice , 2007 .

[28]  Daniel Tzabbar,et al.  The dynamics of knowledge stocks and knowledge flows: innovation consequences of recruitment and collaboration in biotech , 2011 .

[29]  Fr¬¥ed¬¥erique Sachwald,et al.  Co-operative R&D: why and with whom?: An integrated framework of analysis , 2003 .

[30]  Joel Stiebale.  The Impact of Foreign Acquisitions on the Investors' R&D Activities - Firm-Level Evidence , 2010 .

[31]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[32]  F. Rothaermel,et al.  The Effect of General and Partner-Specific Alliance Experience on Joint R&D Project Performance , 2005 .

[33]  R. Gulati.  Does Familiarity Breed Trust? The Implications of Repeated Ties for Contractual Choice in Alliances , 1995 .

[34]  Bart Nooteboom,et al.  Network Embeddedness and the Exploration of Novel Technologies: Technological Distance, Betweenness Centrality and Density , 2006 .

[35]  A. Jaffe.  Technological Opportunity and Spillovers of R&D: Evidence from Firms&Apos; Patents, Profits and Market Value , 1986 .

[36]  Boaz Bernstein,et al.  From Invention to Innovation: Toward Developing an Integrated Innovation Model for Biotech Firms , 2006, Journal of Product Innovation Management.

[37]  D. Newbery,et al.  Preemptive Patenting and the Persistence of Monopoly , 1982 .

[38]  J. Hagedoorn.  Inter-firm R&D partnerships: an overview of major trends and patterns since 1960 , 2002 .

[39]  Manuel Trajtenberg.  Innovation in Israel 1968-97: a Comparative Analysis Using Patent Data , 1999 .

[40]  Tiziana Casciaro,et al.  Determinants of governance structure in alliances: the role of strategic, task and partner uncertainties , 2003 .

[41]  Toby E. Stuart.  Network Positions and Propensities to Collaborate: An Investigation of Strategic Alliance Formation in a High-Technology Industry , 1998 .

[42]  W. Powell,et al.  Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology. , 1996 .

[43]  David L. Deeds,et al.  Exploration and Exploitation Alliances in Biotechnology: A System of New Product Development , 2004 .

[44]  Bart van Looy,et al.  Technological Diversification, Coherence and Performance of Firms , 2007 .

[45]  Christopher Marquis,et al.  Egocentric, sociocentric, or dyadic?: Identifying the appropriate level of analysis in the study of organizational networks , 2006, Soc. Networks.

[46]  Arvids A. Ziedonis,et al.  The growth of patenting and licensing by U.S. universities: an assessment of the effects of the Bayh–Dole act of 1980 , 2001 .

[47]  Pier Paolo Saviotti,et al.  Knowledge characteristics and the dynamics of technological alliances in pharmaceuticals: empirical evidence from Europe, US and Japan , 2014 .

[48]  Z. Griliches.  Patent Statistics as Economic Indicators: a Survey , 1990 .

[49]  Z. Ács,et al.  The knowledge spillover theory of entrepreneurship , 2005 .

[50]  Lucia Cusmano,et al.  Technology Policy and Co-operative R&D the role of Relational Research Capacity , 2000 .

[51]  Christoph Grimpe,et al.  Pre-empting Technology Competition Through Firm Acquisitions , 2008 .

[52]  Patel Parimal,et al.  National Innovation Systems: Why They Are Important, And How They Might Be Measured And Compared , 1994 .

[53]  Geert Duysters,et al.  Collaboration and innovation: a review of the effects of mergers, acquisitions and alliances on innovation , 2005 .

[54]  J. Hennart,et al.  A transaction costs theory of equity joint ventures , 1988 .

[55]  David L. Deeds,et al.  Honeymoons and Liabilities: The Relationship between Age and Performance in Research and Development Alliances , 2003 .

[56]  María García‐Vega.  Does technological diversification promote innovation?: An empirical analysis for European firms , 2006 .

[57]  B. Looy,et al.  Interorganizational collaboration and innovation: Toward a portfolio approach , 2005 .

[58]  D. Mowery,et al.  Technological overlap and interfirm cooperation: implications for the resource-based view of the firm , 1998 .

[59]  David L. Deeds,et al.  Strategic alliances and the rate of new product development: An empirical study of entrepreneurial biotechnology firms , 1996 .

[60]  F. Malerba,et al.  Exploring factors affecting international technological specialization: the role of knowledge flows and the structure of innovative activity , 2003 .

[61]  R. Langlois.  Transaction-cost Economics in Real Time , 1992 .

[62]  Bart Nooteboom,et al.  Optimal cognitive distance and absorptive capacity , 2007 .

[63]  E. Zajac,et al.  Alliance or acquisition? A dyadic perspective on interfirm resource combinations , 2007 .

[64]  N. Pangarkar.  Determinants of Alliance Duration in Uncertain Environments: The Case of the Biotechnology Sector , 2003 .

[65]  Marcus Wagner,et al.  Acquisition as a means for external technology sourcing: Complementary, substitutive or both? , 2011 .

[66]  David J. Teece,et al.  Collaborative Arrangements and Global Technology Strategy: Some Evidence from the Telecommunications Equipment Industry , 1989 .

[67]  Timothy B. Folta.  Governance and uncertainty: the trade‐off between administrative control and commitment , 1998 .